Medtronic plc (MDT) Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 2016 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Medtronic plc quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect history and growth rate from 2016 to 2023.
  • Medtronic plc Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the quarter ending July 28, 2023 was -$204M, a 87% increase year-over-year.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Trailing 12 Months (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Quarterly Data (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$204M +$1.37B +87% Apr 29, 2023 Jul 28, 2023 10-Q 2023-08-31
Q1 2022 -$2.17B -$2.29B -1894% Apr 30, 2022 Apr 28, 2023 10-K 2023-06-22
Q2 2022 -$1.57B -$985M -167% Apr 30, 2022 Jul 29, 2022 10-Q 2023-08-31
Q1 2021 $121M +$668M May 1, 2021 Apr 29, 2022 10-K 2023-06-22
Q2 2021 -$589M -$2.95B -125% May 1, 2021 Jul 30, 2021 10-Q 2022-09-01
Q1 2020 -$547M -$294M -116% Apr 25, 2020 Apr 30, 2021 10-K 2023-06-22
Q2 2020 $2.36B +$1.67B +243% Apr 25, 2020 Jul 31, 2020 10-Q 2021-09-02
Q1 2019 -$253M -$977M -135% Apr 27, 2019 Apr 24, 2020 10-K 2022-06-23
Q2 2019 $687M Apr 27, 2019 Jul 26, 2019 10-Q 2020-09-03
Q1 2018 $724M +$2.02B Apr 28, 2018 Apr 26, 2019 10-K 2021-06-25
Q1 2017 -$1.3B -$3.39B -162% Apr 29, 2017 Apr 27, 2018 10-K 2020-06-19
Q1 2016 $2.09B Apr 30, 2016 Apr 28, 2017 10-K 2019-06-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.